The Path Through The Ovary - The Evolution Of The OPU Needle's Core Role Throughout The Entire Modern ART Cycle

The path through the ovary - the evolution of the OPU needle's core role throughout the entire modern ART cycle
Key words: Targeted puncture OPU needle + Achieving precise follicle selection and efficient recovery of oocytes
In the complete cycle of modern assisted reproductive technology (ART), oocyte retrieval (OPU) has evolved from a simple "follicular fluid extraction" step to a crucial decision-making point that profoundly affects the subsequent embryonic developmental potential, endometrial receptivity, and ultimately the pregnancy outcome. During this process, the OPU needle assumes multiple roles, transitioning from a "retriever of oocytes" to a "microenvironment sampler" and then to a "therapeutic collaborator". Its application spans the entire chain from the starting point of the stimulation protocol to the eve of embryo transfer.
In conventional IVF/ICSI cycles, the OPU needle serves as a balance between efficiency and safety. The standard procedure involves sequentially puncturing each visible follicle. However, the latest strategy emphasizes targeted aspiration: based on the follicle size on the hCG trigger day (the day when hCG is administered), mature dominant follicles with a size of 16-22mm are prioritized for puncture, followed by medium-sized follicles with a size of 12-16mm, and finally small follicles with a size of <12mm. The basis of this strategy is that the composition of follicular fluid, hormone levels, and oxygen pressure in follicles of different sizes are distinct, and mixed aspiration may cause "paracrine contamination", which has an adverse effect on high-quality oocytes. Therefore, the design of the OPU needle supports rapid switching of connection tubes to achieve one puncture, separate follicle collection, providing the possibility for subsequent analysis of follicular fluid biomarkers (such as assessing oxidative stress levels). For patients with a large number of retrieved oocytes, the strategy of performing unilateral ovarian puncture followed by flushing and then puncturing the contralateral ovary can avoid the formation of solidified and blocked follicular fluid in the needle channel due to prolonged operation.
In patients with poor ovarian response (POR), the OPU needle is a precise tool for "rescuing" each precious egg. POR patients have a small number of follicles and often have poor ovarian blood perfusion. At this time, a super-precision 20G or even 21G minimally invasive needle combined with ultra-low negative pressure (80-100 mmHg) becomes the first choice. The key technique is the application of a double-chamber flushing needle: one chamber aspirates the follicular fluid, and the other chamber simultaneously injects preheated culture medium, performing active flushing of the follicular cavity. Studies have confirmed that for small follicles with a diameter of less than 14 mm, the egg retrieval rate by simple aspiration may be less than 60%, while flushing can increase the recovery rate to over 85%. The latest system has achieved intelligent negative pressure regulation: the initial negative pressure is low, and it automatically increases when the follicular fluid flow is stable, decreases again when the follicle collapses, imitating a more gentle physiological emptying process, significantly reducing the shedding of cumulus cells.
In patients with polycystic ovary syndrome (PCOS), the OPU needle serves as a sentinel for preventing ovarian hyperstimulation syndrome (OHSS). PCOS patients have large ovaries, numerous follicles, and abundant blood vessels, making them a high-risk group for OHSS. "Low negative pressure, slow speed, bilateral, and intermittent" becomes the golden rule for egg retrieval. The design of the dedicated needle includes: 1) The side hole at the needle tip has a pressure buffer groove to prevent high negative pressure from directly acting on the capillary network within the ovarian stroma; 2) The proximal end of the needle rod has a pressure release valve, which can be manually released to release the residual negative pressure in the tube after retrieving the oocytes, and then retract the needle to avoid pulling the ovarian tissue during retraction. A more radical but effective strategy is selective follicular puncture: in the early stage of ovulation induction (on the 5th-6th day of the cycle), use the OPU needle to puncture medium-sized follicles (10-14mm) approximately 5-8 times, artificially reducing the number of mature follicles in the end, which can not only obtain usable oocytes but also reduce the risk of moderate to severe OHSS from 8% in the traditional method to below 1%.
In fertility preservation and egg donation cycles, the OPU needle serves as the guardian of time and quality. For cancer patients, fertility preservation requires speed and efficiency to shorten the waiting time for treatment. The high-throughput OPU system integrates multiple channels for suction, allowing for the connection of 2-3 collection tubes, reducing the average puncture and suction time per follicle from 15 seconds to 8 seconds. For egg donation cycles, maintaining the highest quality of donor oocytes is crucial. The temperature-controlled OPU needle sleeve was developed, which continuously circulates a temperature-controlled liquid at 37°C, ensuring that the temperature fluctuation along the entire path from the needle tip to the collection tube is less than 0.5°C, maximizing the protection of the spindle stability of the oocytes. Studies have shown that the eggs obtained using the temperature-controlled system have an absolute increase of 3-5% in the euploid rate of embryos after fertilization.
In the emerging field of follicular fluid diagnostics, the OPU needle serves as the gateway to "liquid biopsy". The follicular fluid obtained during the oocyte retrieval process is rich in biological information that reflects the developmental potential of the oocyte and the ovarian microenvironment. The dedicated segmented collection tubes can be seamlessly connected to the OPU needle to achieve sequential collection of follicles based on their size and individual labeling. Through metabolomics, proteomics, and free DNA analysis of these follicular fluids, non-invasive assessment of mitochondrial function and oxidative stress status of oocytes, as well as prediction of embryonic developmental potential and implantation success rate, can be conducted. Thus, the OPU needle becomes a physical bridge connecting clinical operations with omics big data.
The future OPU will move towards "diagnostic aspiration". The intelligent OPU needle integrates micro-biological sensors, which can immediately analyze the pH value, lactic acid, pyruvic acid, and reactive oxygen species (ROS) levels of the follicular fluid during the puncture process, and assess the "metabolic health" of the follicle in real time. Combined with AI algorithms, the system can advise the operator: which follicles' eggs should be prioritized for fertilization (high potential), which are suitable for cryopreservation (medium potential), and which can be used for research (low potential). The role of the OPU needle will shift from a passive collection tool to an active system for assessing and screening the quality of follicles, laying the most precise and individualized foundation for the success of the entire ART cycle from the very beginning of the aspiration process.